Charles M. Baum - 03 Dec 2021 Form 4 Insider Report for Mirati Therapeutics, Inc.

Signature
/s/ Vickie Reed, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
-$5,886,926
Form type
4
Filing time
03 Dec 2021, 19:09:18 UTC
Previous filing
21 Jun 2021
Next filing
17 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Options Exercise $400,762 +47,204 +42% $8.49* 159,918 03 Dec 2021 Direct F1
transaction MRTX Common Stock Sale $1,210,804 -9,200 -5.8% $131.61 150,718 03 Dec 2021 Direct F1, F2
transaction MRTX Common Stock Sale $2,849,721 -21,509 -14% $132.49 129,209 03 Dec 2021 Direct F1, F3
transaction MRTX Common Stock Sale $519,744 -3,900 -3% $133.27 125,309 03 Dec 2021 Direct F1, F4
transaction MRTX Common Stock Sale $517,023 -3,842 -3.1% $134.57 121,467 03 Dec 2021 Direct F1, F5
transaction MRTX Common Stock Sale $889,539 -6,558 -5.4% $135.64 114,909 03 Dec 2021 Direct F1, F6
transaction MRTX Common Stock Sale $165,361 -1,210 -1.1% $136.66 113,699 03 Dec 2021 Direct F1, F7
transaction MRTX Common Stock Sale $135,495 -985 -0.87% $137.56 112,714 03 Dec 2021 Direct F1, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Employee Stock Option (Right to Buy) Options Exercise $0 -47,204 -100% $0.000000* 0 03 Dec 2021 Common Stock 47,204 $8.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $131.07 to $132.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $132.07 to $133.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $133.07 to $134.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $134.15 to $135.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $135.15 to $136.135. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $136.29 to $137.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 This transaction was executed in multiple trades at prices ranging from $137.34 to $137.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.